DOSE DEPENDENT REDUCTION IN ANTI-DSDNA ANTIBODY LEVELS OBSERVED IN THE ABETIMUS LJP 394-90-14 PHASE 3 TRIAL
Michael P. Madaio, et al
Poster Session
Outcomes and Treatments in the Glomerular Diseases
American Society of Nephrology
Nov 3, 2007
DOSE DEPENDENT REDUCTION IN ANTI-dsDNA ANTIBODY LEVELS OBSERVED IN THE ABETIMUS LJP 394-90-14 PHASE 3 TRIAL
Michael J. Tansey, et al
American College of Rheumatology 2007
Boston, MA
Oct 24, 2007
REDUCTIONS IN ANTIBODIES TO DOUBLE-STRANDED DNA IN LUPUS PATIENTS TREATED WITH ABETIMUS SODIUM IN INTERNATIONAL PHASE 3 STUDY
M. Tansey, et al
Presented at the
The 8th International Congress on SLE
Shanghai, China
May 23-27, 2007
ELECTROCARDIOGRAPHIC SAFETY ASSESSMENT OF ABETIMUS SODIUM IN HEALTHY VOLUNTEERS
M. Linnik, et al
Presented at the
The 8th International Congress on SLE
Shanghai, China
May 23-27, 2007
SAFETY AND PHARMACOKINETIC ASSESSMENT OF ABETIMUS SODIUM IN HEALTHY VOLUNTEERS
M. Linnik, et al
Presented at the
The 8th International Congress on SLE
Shanghai, China
May 23-27, 2007
|
BENEFIT OF INHIBITING SSAO IN RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
A.M O’Rourke, et al
Published in
Journal Neural Transmission
June 2007
Vol. 114, No. 6 pp 845-849
|